Loading…

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie 2021-02, Vol.133 (6), p.3045-3052
Main Authors: Merkul, Eugen, Muns, Joey A., Sijbrandi, Niels J., Houthoff, Hendrik‐Jan, Nijmeijer, Bart, Rheenen, Gerro, Reedijk, Jan, Dongen, Guus A. M. S.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3052
container_issue 6
container_start_page 3045
container_title Angewandte Chemie
container_volume 133
creator Merkul, Eugen
Muns, Joey A.
Sijbrandi, Niels J.
Houthoff, Hendrik‐Jan
Nijmeijer, Bart
Rheenen, Gerro
Reedijk, Jan
Dongen, Guus A. M. S.
description The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially
doi_str_mv 10.1002/ange.202011593
format article
fullrecord <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_journals_2484199650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2484199650</sourcerecordid><originalsourceid>FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3</originalsourceid><addsrcrecordid>eNo9kL9OwzAQxi0EEqWwMltiTrEd598YlVIihcLQ3XJiO3Vp7ZA4hWy8AzMvx5OQUuh0Ot13v_vuA-AaowlGiNxyU8kJQQRhHCT-CRjhgGDPj4LoFIwQotSLCU3OwUXbrhFCIYmSEfhKDZwppUstjYNTa9ZdxZ22BqZ13VherqCyzTDo6o02FbxruqqFzsLFoNpJmBqnCyu0bOFOc-hWEj67LIO5Ni-ygfn773q2HVg7KeAjN53ipesaXuiNdj206p_Rf3987vFHF7K9BGeKb1p59VfHYHk_W04fvPxpnk3T3Kuj2PcCVJTDryX1uYqUwhKjQmBBMPFFQhT3lSKxooJKzGksZExRQUIVizDgZcmlPwY3B-zg8rWTrWNr2zVmuMgIjSlOkjBAgyo5qN70RvasbvSWNz3DiO3jZ_v42TF-li7ms2Pn_wB2kX-x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2484199650</pqid></control><display><type>article</type><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><source>Wiley</source><creator>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</creator><creatorcontrib>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</creatorcontrib><description>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially &lt;15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %. PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</description><identifier>ISSN: 0044-8249</identifier><identifier>EISSN: 1521-3757</identifier><identifier>DOI: 10.1002/ange.202011593</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; antibody–drug conjugates ; Chemistry ; Conjugates ; Conjugation ; Efficiency ; In vivo methods and tests ; Inorganic salts ; Iodides ; linkers ; Manufacturability ; platinum ; Selectivity</subject><ispartof>Angewandte Chemie, 2021-02, Vol.133 (6), p.3045-3052</ispartof><rights>2020 Wiley‐VCH GmbH</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2936-433X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Merkul, Eugen</creatorcontrib><creatorcontrib>Muns, Joey A.</creatorcontrib><creatorcontrib>Sijbrandi, Niels J.</creatorcontrib><creatorcontrib>Houthoff, Hendrik‐Jan</creatorcontrib><creatorcontrib>Nijmeijer, Bart</creatorcontrib><creatorcontrib>Rheenen, Gerro</creatorcontrib><creatorcontrib>Reedijk, Jan</creatorcontrib><creatorcontrib>Dongen, Guus A. M. S.</creatorcontrib><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><title>Angewandte Chemie</title><description>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially &lt;15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %. PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</description><subject>Antibodies</subject><subject>antibody–drug conjugates</subject><subject>Chemistry</subject><subject>Conjugates</subject><subject>Conjugation</subject><subject>Efficiency</subject><subject>In vivo methods and tests</subject><subject>Inorganic salts</subject><subject>Iodides</subject><subject>linkers</subject><subject>Manufacturability</subject><subject>platinum</subject><subject>Selectivity</subject><issn>0044-8249</issn><issn>1521-3757</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kL9OwzAQxi0EEqWwMltiTrEd598YlVIihcLQ3XJiO3Vp7ZA4hWy8AzMvx5OQUuh0Ot13v_vuA-AaowlGiNxyU8kJQQRhHCT-CRjhgGDPj4LoFIwQotSLCU3OwUXbrhFCIYmSEfhKDZwppUstjYNTa9ZdxZ22BqZ13VherqCyzTDo6o02FbxruqqFzsLFoNpJmBqnCyu0bOFOc-hWEj67LIO5Ni-ygfn773q2HVg7KeAjN53ipesaXuiNdj206p_Rf3987vFHF7K9BGeKb1p59VfHYHk_W04fvPxpnk3T3Kuj2PcCVJTDryX1uYqUwhKjQmBBMPFFQhT3lSKxooJKzGksZExRQUIVizDgZcmlPwY3B-zg8rWTrWNr2zVmuMgIjSlOkjBAgyo5qN70RvasbvSWNz3DiO3jZ_v42TF-li7ms2Pn_wB2kX-x</recordid><startdate>20210208</startdate><enddate>20210208</enddate><creator>Merkul, Eugen</creator><creator>Muns, Joey A.</creator><creator>Sijbrandi, Niels J.</creator><creator>Houthoff, Hendrik‐Jan</creator><creator>Nijmeijer, Bart</creator><creator>Rheenen, Gerro</creator><creator>Reedijk, Jan</creator><creator>Dongen, Guus A. M. S.</creator><general>Wiley Subscription Services, Inc</general><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0002-2936-433X</orcidid></search><sort><creationdate>20210208</creationdate><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><author>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>antibody–drug conjugates</topic><topic>Chemistry</topic><topic>Conjugates</topic><topic>Conjugation</topic><topic>Efficiency</topic><topic>In vivo methods and tests</topic><topic>Inorganic salts</topic><topic>Iodides</topic><topic>linkers</topic><topic>Manufacturability</topic><topic>platinum</topic><topic>Selectivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merkul, Eugen</creatorcontrib><creatorcontrib>Muns, Joey A.</creatorcontrib><creatorcontrib>Sijbrandi, Niels J.</creatorcontrib><creatorcontrib>Houthoff, Hendrik‐Jan</creatorcontrib><creatorcontrib>Nijmeijer, Bart</creatorcontrib><creatorcontrib>Rheenen, Gerro</creatorcontrib><creatorcontrib>Reedijk, Jan</creatorcontrib><creatorcontrib>Dongen, Guus A. M. S.</creatorcontrib><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Angewandte Chemie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merkul, Eugen</au><au>Muns, Joey A.</au><au>Sijbrandi, Niels J.</au><au>Houthoff, Hendrik‐Jan</au><au>Nijmeijer, Bart</au><au>Rheenen, Gerro</au><au>Reedijk, Jan</au><au>Dongen, Guus A. M. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</atitle><jtitle>Angewandte Chemie</jtitle><date>2021-02-08</date><risdate>2021</risdate><volume>133</volume><issue>6</issue><spage>3045</spage><epage>3052</epage><pages>3045-3052</pages><issn>0044-8249</issn><eissn>1521-3757</eissn><abstract>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially &lt;15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %. PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/ange.202011593</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2936-433X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0044-8249
ispartof Angewandte Chemie, 2021-02, Vol.133 (6), p.3045-3052
issn 0044-8249
1521-3757
language eng
recordid cdi_proquest_journals_2484199650
source Wiley
subjects Antibodies
antibody–drug conjugates
Chemistry
Conjugates
Conjugation
Efficiency
In vivo methods and tests
Inorganic salts
Iodides
linkers
Manufacturability
platinum
Selectivity
title An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A43%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Efficient%20Conjugation%20Approach%20for%20Coupling%20Drugs%20to%20Native%20Antibodies%20via%20the%20PtII%20Linker%20Lx%20for%20Improved%20Manufacturability%20of%20Antibody%E2%80%93Drug%20Conjugates&rft.jtitle=Angewandte%20Chemie&rft.au=Merkul,%20Eugen&rft.date=2021-02-08&rft.volume=133&rft.issue=6&rft.spage=3045&rft.epage=3052&rft.pages=3045-3052&rft.issn=0044-8249&rft.eissn=1521-3757&rft_id=info:doi/10.1002/ange.202011593&rft_dat=%3Cproquest_wiley%3E2484199650%3C/proquest_wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2484199650&rft_id=info:pmid/&rfr_iscdi=true